JPM: NVIDIA and Eli Lilly announce co-innovation AI lab
JPM: NVIDIA and Eli Lilly announce co-innovation AI lab | MobiHealthNews
Skip to main content…
Continue Reading
Tag: Eli Lilly
NVIDIA and Eli Lilly Launch AI Co-Innovation Lab to Reinvent Drug Discovery
What You Should Know
– NVIDIA and Eli Lilly and Company have announced a historic $1B, five-year investment to launch an AI co-innovation lab in the San Francisco Bay Area.
– Utilizing the NVIDIA BioNeMo platform…
Continue Reading
Eli Lilly Taps Chai Discovery’s Frontier AI to Design ‘Computer-Aided’ Biologics
What You Should Know
– Eli Lilly and Company has entered a strategic collaboration with Chai Discovery to deploy frontier AI for the design of novel biologic therapeutics.
– The partnership includes the development of an…
Continue Reading
Why MBX Capital is Betting $100M on the Link Between Industrial Toxins and Chronic Disease
What You Should Know:
– MBX Capital has secured over $100M in capital commitments to invest in early-stage biotech and health tech companies, specifically focusing on “deep health” solutions that address diseases linked to environmental…
Continue Reading
Trump Unveils Historic Drug Price Cuts: Ozempic and Wegovy Reduced to $350 via TrumpRx
What You Should Know:
– President Donald J. Trump announced the latest in a series of significant actions to lower prescription drug prices, unveiling agreements with pharmaceutical manufacturers Eli Lilly and Company and Novo Nordisk.
–…
Continue Reading
Learnings and Innovations from the HLTH 2025 Conference – Part 4
If you’ve been following us on our social media channels (John Lynn, Colin Hung, and Healthcare IT Today), you’ll know that last week we were connecting and learning with the health IT professionals at…
Continue Reading
Eli Lilly Partners Walmart for Zepbound Pickup
Introduction
In a groundbreaking move that reshapes direct-to-consumer pharmaceutical access, Eli Lilly has partnered with Walmart to offer in-store pickup services for Zepbound vials. This collaboration represents the first retail pharmacy partnership for LillyDirect, Eli…
Tandem Diabetes Care’s t:slim X2 Pump Cleared for Use with Lilly’s Ultra-Rapid Lyumjev® Insulin
What You Should Know:
– Tandem Diabetes Care, an insulin delivery and diabetes technology company, has announced that its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology is now cleared for use…
Continue Reading
Eli Lilly’s Oral GLP-1 Orforglipron Successful in Third Phase 3 Trial
What You Should Know:
– Eli Lilly and Company has announced positive topline results from its Phase 3 ATTAIN-2 trial, which evaluated orforglipron, an investigational oral GLP-1 receptor agonist, in adults with obesity or overweight…
Continue Reading
Persist AI secures $12M Series A Funding, unveiled Cloud Lab platform
Persist AI, an AI-driven robotics platform for the pharmaceutical industry, announced an overscribed $12 million Series A funding round.Spero Ventures led the round with participation from MBX Capital, Shimadzu Future Innovation Fund managed by…
Continue Reading